An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
|Articles|September 18, 2014
Executive Order Issued on Combating Antibiotic-Resistant Bacteria
Advertisement
Today, the President announced a new Executive Order and
to address recommendations identified by the President’s Council of Advisors on Science and Technology (PCAST).
As a leader in monitoring and preventing the spread of resistant infections, the Centers for Disease Control and Prevention (CDC) will leverage its expertise and build on core strengths to:
• Slow the development of resistant bacteria and prevent the spread of resistant infections.
• Strengthen National One-Health surveillance efforts to combat resistance.
• Advance development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria.
• Improve international collaboration and capacities for antibiotic resistance prevention, surveillance, control and antibiotic research and development.
This year alone, at least two million Americans will become sickened by antibiotic resistant infections, and 23,000 Americans will die. Antibiotic resistance costs the U.S. more than $20 billion in healthcare expenses each year.
These important plans are part of a request for $30 million for CDC’s Detect and Protect Initiative and $14 million of the National Healthcare Safety Network to ramp up this fight. These strategies and the funds needed to implement them are a down-payment to improve the nation’s ability to tackle the biggest drug-resistant threats.
To find out more about CDC and antibiotic resistance, read a
Source: CDC
Advertisement
Related to this article
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
UPMC’s genomic surveillance initiative earned national recognition for patient safety. Alexander Sundermann, DrPH, CIC, FAPIC, AL-CIP, explains how the award could help infection preventionists secure leadership support and sustainable funding for earlier outbreak detection.
Knowing the protocol is only the beginning. In The Clean Bite, Sherrie Busby explores how explaining the why, addressing staff concerns, and creating clear procedures can help dental teams make infection control part of everyday practice.
What might infection prevention rounds miss when visible conditions dominate the conversation? Tommy Davis, PhD, CMIP, a member of ICT's executive advisory board, makes the case for structured observations of clinical workflows, shared accountability, and greater attention to environmental services staff’s insights.
A proposed $27.7 million reduction in AHRQ funding raises questions about support for infection prevention research and implementation. Here is what the September 25 announcement identifies, as well as what remains unknown about specific IPC programs.
Advertisement
Advertisement